drugset / Trial / NCT05553587
Symptoms and Physiological Effects of Amara in Functional Dyspepsia
NaSingle-groupOpen-labelTreatment
Summary
The primary aim of this investigator-initiated, prospective, open-label study is to assess perceived changes in symptom burden reported by in patients with functional dyspepsia treated with Amara. Additionally, the physiological effects of Amara on gastric motor and sensory function will be assessed using validated methods.
Timeline
- Start
- 2022-07-22
- Primary completion
- 2025-02-28
- Completion
- 2025-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amara Drops | Unknown | 0.25 ml | Oral |
| Subject | Amara Drops | Unknown | 0.5 ml | Oral |